Please use this identifier to cite or link to this item:
Title: Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia
Authors: Hazra, Monica
Uchida, Hiroyuki
Sproule, Beth A.
Remington, Gary
Suzuki, Takefumi
Mamo, David
Keywords: Antipsychotic drugs
Issue Date: 2011
Publisher: Wiley-Blackwell Publishing Asia
Citation: Hazra, M., Uchida, H., Sproule, B., Remington, G., Suzuki, T., & Mamo, D. C. (2011). Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. Psychiatry and Clinical Neurosciences, 65(7), 676-678.
Abstract: The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.
Appears in Collections:Scholarly Works - FacM&SPsy

Files in This Item:
File Description SizeFormat 
  Restricted Access
45.87 kBAdobe PDFView/Open Request a copy

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.